TICAGRELOR tablets (Brilique®) - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

TICAGRELOR tablets (Brilique®)

Last Updated: 25 January 2017

Body System: Cardiovascular system

Amber initiated

The Pan Mersey Area Prescribing Committee recommends the prescribing of TICAGRELOR tablets (Brilique®), following specialist initiation, for the management of acute coronary syndromes in adults in accordance with NICE TA236 and for preventing atherothrombotic events after myocardial infarction in accordance with NICE TA420.